Ciclesonide (Alvesco) showing promise for COVID-19 in Japan
Development of coronavirus treatment advancing in Japan with existing meds
"One medicine that experts in a government panel have expressed hope in is Ciclesonide (marketed as Alvesco), a type of steroid used in inhalers to treat asthma. A medical team including members of the Kanagawa Prefectural Ashigarakami Hospital administered this drug to three coronavirus disease patients. One of them, a woman in her 70s, saw her fever go down after two days, and her pneumonia symptoms also improved. She later tested negative for the virus and was discharged from hospital after eight days. The other two patients, a man in his 70s and a woman in her 60s, were able to be taken off respirators after receiving the medicine. Currently around 10 people are receiving it."
https://mainichi.jp/english/articles/20200317/p2a/00m/0na/026000c